Chem
J-GLOBAL ID:200907078422781870   Nikkaji number:J984I

Dihydroergocristine

ジヒドロエルゴクリスチン
Substance type:
Substance type
Substance type classified into 3 categories.
Decided structure: Substances with a clear structure
Undicided Structure: Substances with unknown or undetermined structure
Mixtures: Mixtures, racemic compounds, or compounds with relative structural arrangements
Decided structure
Molecular formula: C35H41N5O5
Molecular formula furigana: C35-H41-N5-O5
Molecular weight: 611.743
InChI: InChI=1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)/t23-,25-,27-,28+,29+,34-,35+/m1/s1
InChI key: DEQITUUQPICUMR-HJPBWRTMSA-N
SMILES: CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O
Systematic name  (5):
  • (5′α,10α)-9,10-ジヒドロ-12′-ヒドロキシ-2′-(1-メチルエチル)-5′-(フェニルメチル)エルゴタマン-3′,6′,18-トリオン
  • 9,10α-ジヒドロ-12′-ヒドロキシ-2′-イソプロピル-5′α-(フェニルメチル)エルゴタマン-3′,6′,18-トリオン
  • 9,10α-ジヒドロ-12′-ヒドロキシ-2′-イソプロピル-5′α-ベンジルエルゴタマン-3′,6′,18-トリオン
  • (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-ベンジル-2-ヒドロキシ-5,8-ジオキソ-4-(プロパン-2-イル)-3-オキサ-6,9-ジアザトリシクロ[7.3.0.02,6]ドデカン-4-イル]-6-メチル-6,11-ジアザテトラシクロ[7.6.1.02,7.012,16]ヘキサデカ-1(16),9,12,14-テトラエン-4-カルボキサミド
  • (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide
Other name (6):
  • ジヒドロエルゴクリスチン
  • Dihydroergocristine
  • 9,10α-Dihydro-12′-hydroxy-2′-isopropyl-5′α-benzylergotaman-3′,6′,18-trione
  • 9,10α-Dihydro-12′-hydroxy-2′-isopropyl-5′α-(phenylmethyl)ergotaman-3′,6′,18-trione
  • 9,10-ジヒドロエルゴクリスチン
Show all
CAS registry number: 17479-19-5
Regulation number (2):
  • 8-(2)-1100
  • EINECS2414934
KEGG DRUG: D07834
Application (3):
adrenergic blocking drug ,  circulatory drug ,  alpha adrenergic antagonist
Thsaurus map:

Return to Previous Page